Maxine H. Simmons

Cellomics, Inc. provides imaging technology products and services. It is a provider of technologies and products for the advancement of cell science research, including complete systems for high-content imaging of cells, tissues and whole organisms. The firm's platform includes automated imaging instruments, image analysis software, data management and bioinformatics software, coupled with reagents, cell-culture media, sera and specialty media formulations, along with laboratory automation and services. The company's offering is aimed at providing life science researchers with a quantitative, automated approach to understanding the biology of cells, including stem cells and cell systems, supporting all aspects of the drug discovery process as well as academic and systems biology research. Cellomics was founded on October 1996 and is headquartered in Pittsburgh, PA.

Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.

Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA.

Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA.

The Chartered Institute of Marketing (CIM) is professional marketing body with above 50,000 members in 130 countries. Its International Offices are situated in Malaysia, Sri Lanka, Hong Kong and Singapore. The Chartered Institute of Marketing is headquartered in Maidenhead, UK

Catalyst Investments LP (Management) (Catalyst) is a private equity subsidiary of Cukierman & Co. founded in 1999 by Cukierman Edouard and Yair Shamir. The firm is headquartered in Tel Aviv, Israel.

Caliper, Inc. provides recruiting and screening services. Its services include temporary, Temp--Hire, direct hire, executive search, payrolling, vendor on premise and single source management/managed staffing services. The company was founded in 1983 and is headquartered in Virginia Beach, VA.

Whatman, Inc. develops, manufactures, and markets separation technology devices. Its products are used for filtration, purification and storage of chemicals, and other liquids & samples. It is a subsidiary of Whatman Plc. The company was founded in 1961 and is headquartered in Florham Park, NJ.

ZyGEM NZ Ltd. operates as a biotechnology company. It offers applications in a broad range of life sciences and industrial processes. The firm produces deoxyribonucleic acid extraction products, as well as enzymes used in molecular biology, diagnostics, and industrial applications. The company was founded in 2005 and is headquartered in Hamilton, New Zealand.

Industrial Research Ltd. provides research and development services in the manufacturing and service sectors. The company was founded in 1992 and is headquartered in Wellington, New Zealand.

Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand.

Pacific Channel Ltd (Pacific Channel) is a venture capital firm founded in 2006 by Brent S. Ogilvie. The firm is headquartered in Auckland, New Zealand.

NuPlant operates as a biotechnology firm. It offers SmartClone technologies to produce clonal propagation material of selected crops in its own tissue culture facility. The company headquartered in Toowong, Australia.

NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand.

Building Research Association of New Zealand is an independent and impartial research, testing, and consulting New Zealander company. The private company is based in Porirua, New Zealand.

Objective Acuity Ltd. develops vision testing equipment to detect visual function. The company was founded by Benjamin Thompson, Jason Turuwhenua and Mehrdad Sangi and is headquartered in Auckland, New Zealand.

Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom.

Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy.

Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.